Key statistics
On Monday, AN2 Therapeutics Inc (ANTX:NSQ) closed at 1.04, 19.54% above the 52 week low of 0.87 set on Aug 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.06 |
---|---|
High | 1.08 |
Low | 1.04 |
Bid | 1.04 |
Offer | 1.09 |
Previous close | 1.05 |
Average volume | 238.59k |
---|---|
Shares outstanding | 29.84m |
Free float | 22.27m |
P/E (TTM) | -- |
Market cap | 31.33m USD |
EPS (TTM) | -2.26 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 21:00 BST.
More ▼
- AN2 Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- AN2 Therapeutics Adopts Limited Duration Stockholder Rights Plan
- AN2 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business and Scientific Highlights
- AN2 Therapeutics Provides Update on EBO-301 Phase 2/3 Study Evaluating Epetraborole for Treatment-Refractory Mycobacterium avium Complex (MAC) Lung Disease